The Role of Galectins in Asthma Pathophysiology: A Comprehensive Review

Overview

Journal Curr Issues Mol Biol

Publisher MDPI

Specialty Molecular Biology

Date 2024 May 24

PMID 38785528

Authors

Andrea Portacci

Ilaria Iorillo

Leonardo Maselli

Monica Amendolara

Vitaliano Nicola Quaranta

Silvano Dragonieri

Giovanna Elisiana Carpagnano

Affiliations

Soon will be listed here.

Abstract

Galectins are a group of β-galactoside-binding proteins with several roles in immune response, cellular adhesion, and inflammation development. Current evidence suggest that these proteins could play a crucial role in many respiratory diseases such as pulmonary fibrosis, lung cancer, and respiratory infections. From this standpoint, an increasing body of evidence have recognized galectins as potential biomarkers involved in several aspects of asthma pathophysiology. Among them, galectin-3 (Gal-3), galectin-9 (Gal-9), and galectin-10 (Gal-10) are the most extensively studied in human and animal asthma models. These galectins can affect T helper 2 (Th2) and non-Th2 inflammation, mucus production, airway responsiveness, and bronchial remodeling. Nevertheless, while higher Gal-3 and Gal-9 concentrations are associated with a stronger degree of Th-2 phlogosis, Gal-10, which forms Charcot-Leyden Crystals (CLCs), correlates with sputum eosinophilic count, interleukin-5 (IL-5) production, and immunoglobulin E (IgE) secretion. Finally, several galectins have shown potential in clinical response monitoring after inhaled corticosteroids (ICS) and biologic therapies, confirming their potential role as reliable biomarkers in patients with asthma.

Citing Articles

Can Galectin-3 Be Used as a Predictor of Obstructive Sleep Apnea Severity: Insights from High-Volume Patient Single Center.

Brajkovic M, Nikolic S, Popadic V, Milic N, Rajovic N, Nikolic N Diagnostics (Basel). 2025; 15(3).

PMID: 39941305 PMC: 11817275. DOI: 10.3390/diagnostics15030375.

Disease Modification in Asthma: Are We on the Right Way? A Multidisciplinary Expert Delphi Consensus (MODIASTHMA Consensus).

Miralles-Lopez J, Alvarez-Gutierrez F, Delgado-Romero J, Quirce S, Soto-Campos J, Andujar-Espinosa R J Asthma Allergy. 2024; 17:1163-1171.

PMID: 39558970 PMC: 11571985. DOI: 10.2147/JAA.S488764.

References

Scioscia G, Nolasco S, Campisi R, Quarato C, Caruso C, Pelaia C . Switching Biological Therapies in Severe Asthma. Int J Mol Sci. 2023; 24(11). PMC: 10253346. DOI: 10.3390/ijms24119563. View

Kobayashi K, Nagase H, Sugimoto N, Yamamoto S, Tanaka A, Fukunaga K . Mepolizumab decreased the levels of serum galectin-10 and eosinophil cationic protein in asthma. Asia Pac Allergy. 2021; 11(3):e31. PMC: 8331256. DOI: 10.5415/apallergy.2021.11.e31. View

Rodriguez-Alcazar J, Ataide M, Engels G, Schmitt-Mabmunyo C, Garbi N, Kastenmuller W . Charcot-Leyden Crystals Activate the NLRP3 Inflammasome and Cause IL-1β Inflammation in Human Macrophages. J Immunol. 2018; 202(2):550-558. DOI: 10.4049/jimmunol.1800107. View

Portacci A, Amendolara M, Quaranta V, Iorillo I, Buonamico E, Diaferia F . Can Galectin-3 be a reliable predictive biomarker for post-COVID syndrome development?. Respir Med. 2024; 226:107628. DOI: 10.1016/j.rmed.2024.107628. View

Alexander W . Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol. 2002; 2(6):410-6. DOI: 10.1038/nri818. View

Ho M, Springer T . Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. J Immunol. 1982; 128(3):1221-8. View

Gordon E, Sidhu S, Wang Z, Woodruff P, Yuan S, Solon M . A protective role for periostin and TGF-β in IgE-mediated allergy and airway hyperresponsiveness. Clin Exp Allergy. 2011; 42(1):144-55. PMC: 3271792. DOI: 10.1111/j.1365-2222.2011.03840.x. View

Erriah M, Pabreja K, Fricker M, Baines K, Donnelly L, Bylund J . Galectin-3 enhances monocyte-derived macrophage efferocytosis of apoptotic granulocytes in asthma. Respir Res. 2019; 20(1):1. PMC: 6318889. DOI: 10.1186/s12931-018-0967-9. View

Yakushina V, Vasileva O, Ryazantseva N, Novitsky V, Tashireva L . The effects of galectin-1 on the gene expression of the transcription factors TBX21, GATA-3, FOXP3 and RORC. Mol Cell Biochem. 2014; 398(1-2):245-9. DOI: 10.1007/s11010-014-2227-8. View

10.

Mammen M, Sands M, Abou-Jaoude E, Aalinkeel R, Reynolds J, Parikh N . Role of Galectin-3 in the pathophysiology underlying allergic lung inflammation in a tissue inhibitor of metalloproteinases 1 knockout model of murine asthma. Immunology. 2017; 153(3):387-396. PMC: 5795177. DOI: 10.1111/imm.12848. View

11.

Jackson D, Heaney L, Humbert M, Kent B, Shavit A, Hiljemark L . Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study. Lancet. 2023; 403(10423):271-281. DOI: 10.1016/S0140-6736(23)02284-5. View

12.

Iwasaki-Hozumi H, Chagan-Yasutan H, Ashino Y, Hattori T . Blood Levels of Galectin-9, an Immuno-Regulating Molecule, Reflect the Severity for the Acute and Chronic Infectious Diseases. Biomolecules. 2021; 11(3). PMC: 7998537. DOI: 10.3390/biom11030430. View

13.

Takeda M, Ueki S, Yamamoto Y, Nara M, Fukuchi M, Nakayama K . Hypereosinophilic syndrome with abundant Charcot-Leyden crystals in spleen and lymph nodes. Asia Pac Allergy. 2020; 10(3):e24. PMC: 7402945. DOI: 10.5415/apallergy.2020.10.e24. View

14.

Fujisawa T, Velichko S, Thai P, Hung L, Huang F, Wu R . Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm. J Immunol. 2009; 183(10):6236-43. PMC: 4623590. DOI: 10.4049/jimmunol.0900614. View

15.

Katoh S, Matsumoto N, Kawakita K, Tominaga A, Kincade P, Matsukura S . A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia. J Clin Invest. 2003; 111(10):1563-70. PMC: 155042. DOI: 10.1172/JCI16583. View

16.

Perone M, Bertera S, Shufesky W, Divito S, Montecalvo A, Mathers A . Suppression of autoimmune diabetes by soluble galectin-1. J Immunol. 2009; 182(5):2641-53. PMC: 2929001. DOI: 10.4049/jimmunol.0800839. View

17.

Yousefi S, Gold J, Andina N, Lee J, Kelly A, Kozlowski E . Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med. 2008; 14(9):949-53. DOI: 10.1038/nm.1855. View

18.

Gevaert E, Delemarre T, De Volder J, Zhang N, Holtappels G, De Ruyck N . Charcot-Leyden crystals promote neutrophilic inflammation in patients with nasal polyposis. J Allergy Clin Immunol. 2019; 145(1):427-430.e4. DOI: 10.1016/j.jaci.2019.08.027. View

19.

Portacci A, Diaferia F, Santomasi C, Dragonieri S, Boniello E, Di Serio F . Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure. Respir Med. 2021; 187:106556. PMC: 8332745. DOI: 10.1016/j.rmed.2021.106556. View

20.

Katoh S, Ishii N, Nobumoto A, Takeshita K, Dai S, Shinonaga R . Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am J Respir Crit Care Med. 2007; 176(1):27-35. DOI: 10.1164/rccm.200608-1243OC. View